Tofacitinib

Drug Name
Tofacitinib

Brand Name(s)
Xeljanz®

Drug Class
Janus Kinase (JAK) Inhibitor

Tofacitinib is a DMARD used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA).


This information was written in November 2017, with expert advice from:

Jason Kielly, B.Sc. (pharm.), Pharm.D.
Assistant Professor, School of Pharmacy, Memorial University of Newfoundland
Clinical Pharmacist, Rheumatic Health Program, Eastern Health

This information was last updated in December 2021 by:

Alan Low, B.Sc. (pharm.), Pharm. D., ACPR, FCSHP, CCD, RPh
Clinical Associate Professor, Faculty of Pharmaceutical Sciences, UBC
Co-Founder and Executive Director, Medicines Access Coalition – BC
Primary Care Pharmacist, Vancouver

Go Back to Drug Index